832 Results

People

  1. Pfister
    Pfister
  2. Lee
    Lee
  3. Sherman
    Sherman
  4. Riaz
    Riaz
  5. Dunn
    Dunn
  6. Wong
    Wong
  7. Ho
    Ho
  8. McBride
    McBride
  9. Shah
    Shah
  10. Tsai
    Tsai

Groups

  1. Head and Neck Service (832)
  2. Solid Tumor Oncology Division (832)
  3. Department of Medicine (826)
  4. Surgery (358)
  5. Radiation Oncology, Department of (310)
  6. Survivorship Research (310)
  7. Center for Pancreatic Cancer Research (173)
  8. Epidemiology and Biostatistics (162)
  9. Weinberg Fellows (161)
  10. Department of Pathology and Laboratory Medicine (155)
  1. "Head and Neck Service"
Formats
  1. Journal Article (407)
  2. Meeting Abstract (360)
  3. Book Section (20)
  4. Review (19)
  5. Editorial (7)
  6. Guidelines (7)
  7. Research Letter (6)
  8. Correspondence (3)
  9. Book Whole (1)
  10. Conference Paper (1)
  11. Miscellaneous (1)
Groups
  1. Head and Neck Service (832)
  2. Solid Tumor Oncology Division (832)
  3. Department of Medicine (826)
  4. Surgery (358)
  5. Radiation Oncology, Department of (310)
  6. Survivorship Research (310)

More Groups

People
  1. David Pfister (389)
  2. Eric Sherman (339)
  3. Nancy Lee (266)
  4. Alan Ho (238)
  5. Nadeem Riaz (159)
  6. Lara Dunn (141)

More People

Years
  1. 2025 (12)
  2. 2024 (72)
  3. 2023 (55)
  4. 2022 (57)
  5. 2021 (58)
  6. 2020 (66)

More Years

Publications
  1. Journal of Clinical Oncology (205)
  2. International Journal of Radiation Oncology, Biology, Physics (140)
  3. Annals of Oncology (43)
  4. Cancer (33)
  5. Head & Neck (28)
  6. Journal of the National Comprehensive Cancer Network (28)

More Publications

Publishers
  1. American Society of Clinical Oncology (219)
  2. Elsevier Inc. (176)
  3. Wiley Blackwell (55)
  4. Oxford University Press (53)
  5. American Association for Cancer Research (46)
  6. Harborside Press (28)

More Publishers

Results (832)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer
    Journal Article

    Fury, M. G.; Haque, S.; Stambuk, H.; Shen, R.; Carlson, D.; Pfister, D.
    Cancer (2011)

    Fulltext@MSK | Save
  • Phase II study of saracatinib (AZD0530) for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC)
    Journal Article

    Fury, M. G.; Baxi, S.; Shen, R.; Kelly, K. W.; Lipson, B. L.; Carlson, D.; Stambuk, H.; Haque, S.; Pfister, D. G.
    Anticancer Research (2011)

    Fulltext@MSK | Save
  • A phase II study of VEGF trap (aflibercept) in patients with radioactive iodine-refractory, positron emission tomography (PET) positive thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Haque, S.; Ghossein, R. A.; Lisa, D. M.; Schoder, H.; Baum, M. S.; Shaha, A. R.; Tuttle, R. M.; Pfister, D. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase II study of pemetrexed (P) plus gemcitabine (G) in patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)
    Meeting Abstract

    Pfister, D. G.; Haque, S.; Stambuk, H.; Lisa, D. M.; Shen, R.; Carlson, D.; Fury, M. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Long-term results in a cohort of medullary thyroid cancer (MTC) patients (pts) in a phase I study of XL184 (BMS 907351), an oral inhibitor of MET, VEGFR2, and RET
    Meeting Abstract

    Kurzrock, R.; Cohen, E. E.; Sherman, S. I.; Pfister, D. G.; Cohen, R. B.; Ball, D.; Hong, D. S.; Ng, C. S.; Salgia, R.; Ratain, M. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase I study of everolimus (E) plus low-dose weekly cisplatin (C) for patients with advanced solid tumors
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Wu, N.; Haque, S.; Lisa, D. M.; Carlson, D.; Pfister, D. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Intensity modulated radiation therapy for oropharyngeal carcinoma: Clinical outcomes and longitudinal analysis of late effects
    Meeting Abstract

    Lian, M.; Setton, J.; Wolden, S. L.; Caria, N.; Schupak, K. D.; Gelblum, D. Y.; Wong, R. J.; Sherman, E. J.; Fury, M. G.; Lee, N. Y.
    International Journal of Radiation Oncology, Biology, Physics (2010)

    Fulltext@MSK | Save
  • Phase II study of concurrent and adjuvant chemotherapy with intensity modulated radiation therapy (IMRT) or three-dimensional conformal radiotherapy (3D-CRT) plus bevacizumab (BV) for locally or regionally advanced nasopharyngeal cancer (NPC) RTOG 0615 : Preliminary toxicity report
    Meeting Abstract

    Lee, N.; Zhang, Q.; Kim, J.; Garden, A. S.; Mechalakos, J.; Hu, K.; Le, Q.; Glisson, B. S.; Chan, A. T.; Pfister, D. G.
    International Journal of Radiation Oncology, Biology, Physics (2010)

    Fulltext@MSK | Save
  • Cisplatin (CDDP) and radiation (RT) versus cetuximab (C) and RT in the context of human papillomavirus (HPV) and P16 in the treatment of locally advanced head and neck cancer (LAHNC)
    Meeting Abstract

    Koutcher, L. D.; Sherman, E.; Carlson, D.; Katabi, N.; Fury, M.; Wolden, S.; Zhang, Z.; Mo, Q.; Pfister, D.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2010)

    Fulltext@MSK | Save
  • Adjuvant trastuzumab reduces locoregional recurrence in women who undergo breast conservation therapy for node-negative HER2-positive breast cancer
    Journal Article

    Kiess, A. P.; Mcarthur, H. L.; Mahoney, K.; Patil, S.; Morris, P. G.; Ho, A.; Hudis, C. A.; McCormick, B.
    International Journal of Radiation Oncology, Biology, Physics (2010)

    Fulltext@MSK | Save